The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.

Hsu CY, Abdulrahim MN, Mustafa MA, Omar TM, Balto F, Pineda I, Khudair TT, Ubaid M, Ali MS

Open source

DOI
10.1007/s12032-024-02435-0
Published
2024 Jul 15
Container
Medical oncology (Northwood, London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12032-024-02435-0,
  title = {The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.},
  author = {Hsu CY and Abdulrahim MN and Mustafa MA and Omar TM and Balto F and Pineda I and Khudair TT and Ubaid M and Ali MS},
  year = {2024},
  journal = {Medical oncology (Northwood, London, England)},
  doi = {10.1007/s12032-024-02435-0},
  url = {https://doi.org/10.1007/s12032-024-02435-0}
}

RIS

TY  - JOUR
TI  - The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.
AU  - Hsu CY
AU  - Abdulrahim MN
AU  - Mustafa MA
AU  - Omar TM
AU  - Balto F
AU  - Pineda I
AU  - Khudair TT
AU  - Ubaid M
AU  - Ali MS
PY  - 2024
JO  - Medical oncology (Northwood, London, England)
DO  - 10.1007/s12032-024-02435-0
UR  - https://doi.org/10.1007/s12032-024-02435-0
ER  - 

APA

CY, H., MN, A., MA, M., TM, O., F, B., I, P., TT, K., M, U., & MS, A. (2024). The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.. Medical oncology (Northwood, London, England). https://doi.org/10.1007/s12032-024-02435-0

Source records